ใ€Š๐Ÿ…CEO of NPD Goro Akechiใ€‹(@marsmaboy) 's Twitter Profile Photo

Cale drank something he wasn't supposed to from the lab..... Ammerich (ALorem) and NLorem freak out

also censored bc Ammerich isnt politically correct lmao

Cale drank something he wasn't supposed to from the lab..... Ammerich (ALorem) and NLorem freak out

also censored bc Ammerich isnt politically correct lmao
account_circle
Target ALS(@TargetALS_fdn) 's Twitter Profile Photo

Target ALS is committed to finding treatments for all forms of ALS.

We are proud of our collaboration with n-Lorem Foundation Foundation to find treatments for nano-rare forms of ALS.

account_circle
Nitto Americas(@NittoAmericas) 's Twitter Profile Photo

Nitto Avecia and n-Lorem Foundation are partnering to strengthen the development of personalized for patients with rare diseases.

Read the announcement: bwnews.pr/3x9NDG8

account_circle
Patsy NFT(@AutumnT65221862) 's Twitter Profile Photo

@B0kiNFT Mona Lisa @iszsrn @udongyue3 @aldeboi19 @opketmon @unami_eth @gorfirst @0rdmarlborough ayie daniel lavado @amboozlezy @arthxnft @uxekas @rutale91o_nft sophon @ujikfamily Pierre Toussaint @ayshifter1 minwoo Lee @hangbaoNFT @reeniedoteth @aniel_ldn_nft @ragosh672 Nadia Medina

account_circle
Joseph G. Gleeson(@jogleeson_ucsd) 's Twitter Profile Photo

Eric Vallabh Minikel Daniel MacArthur Erika Check Hayden Tim Yu Thanks for alerting the community. is taking this issue seriously and taking with the to ensure future safety. thinks the issue is largely preventable by following industry-standard guidelines. Drug design should be left to professionals.

account_circle
Joseph G. Gleeson(@jogleeson_ucsd) 's Twitter Profile Photo

Ethan Perlstein Erika Check Hayden Eric Vallabh Minikel Daniel MacArthur Tim Yu Excellent point, Ethan. ASOs seem simple solutions for genetic diseases. But 30+ year of industry experience canโ€™t be discounted. Patients are free to make decisions, but such leverage best available in partnership. The alternative is potentially life-threatening risk.

account_circle
Ana Mingorance(@CNSdrughunter) 's Twitter Profile Photo

How rare are N-of-1 trials with personalized ASOs?

We all know of Mila (Mila's Miracle) and maybe 2-3 more, but real numbers are much higher! Joseph G. Gleeson says just at nLorem they have helped 50 patients get a personalized ASO.
Look forward to seeing more access! ๐Ÿงฌโžก๏ธ๐Ÿง’

account_circle
Profit Studio 81(@ProfitStudio1) 's Twitter Profile Photo

What is Lorem Ipsum?Why do we use it?Where does it come from?Where can I get som - Clone (1) - Clone (1)\nLorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since t

account_circle
Arnav Roy(@aroy81547) 's Twitter Profile Photo

In this clip, I asked Stanley Crooke, founder of Ionis Pharmaceuticals, Inc. and nLorem, what advice he would give to his younger self if he could.

youtu.be/T4lAYpgMHH0


account_circle
Arnav Roy(@aroy81547) 's Twitter Profile Photo

Season 1, Episode 26: Had the pleasure to sit down with Stanley Crooke, founder and former CEO of Ionis, Inc. for over 30 years, and now the founder and CEO of nLorem.

youtu.be/YSQeCzdrjes

.
.
.


account_circle